Tetrology of Fallot

Reading File
Finding Sources
Searching PubMed

"Tetralogy of Fallot"[MeSH Terms]

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Reading File
Here is a comprehensive overview of Tetralogy of Fallot (ToF).

Tetralogy of Fallot

Definition & Epidemiology

Tetralogy of Fallot is the most common cyanotic congenital heart disease, accounting for ~5% of all congenital cardiac malformations, with an incidence of approximately 420 per million live births.

The Four Cardinal Defects

All four features arise from a single embryologic defect: anterosuperior displacement of the infundibular (outlet) septum, causing unequal division of the truncus arteriosus.
#DefectDetails
1Right Ventricular Outflow Tract (RVOT) ObstructionUsually subpulmonic (infundibular) stenosis; may be valvular stenosis or complete pulmonary atresia
2Large, Unrestrictive VSDNear the membranous septum; allows bidirectional shunting
3Overriding AortaAortic valve straddles the VSD, receiving blood from both ventricles
4Right Ventricular HypertrophySecondary to high pressure load from RVOT obstruction
Classic Tetralogy of Fallot — showing RV, LV, VSD, overriding aorta (Ao), and hypoplastic pulmonary trunk (PT)
Classic ToF: right-to-left shunting across the VSD. Ao = Aorta, PT = Pulmonary Trunk, RA/RV/LA/LV = cardiac chambers. (Robbins & Kumar Basic Pathology)

Pathophysiology

The physiologic result is decreased pulmonary blood flow + right-to-left shunting of deoxygenated blood across the VSD into the aorta.
Blood flow diagram in ToF — deoxygenated blood (blue) shunted through VSD past the RVOT obstruction (OB) into the overriding aorta (OAo), producing mixed oxygenation in the systemic circulation
Hemodynamics of ToF: severity of shunt depends on degree of RVOT obstruction, VSD size, and systemic vascular resistance (SVR). (Rosen's Emergency Medicine)
  • Severity is proportional to the degree of RVOT obstruction
  • Mild obstruction → left-to-right shunt only → "Pink Tet" (acyanotic)
  • Severe obstruction → early profound cyanosis
  • In pulmonary atresia: pulmonary flow entirely via PDA or bronchial collaterals

Morphology

  • Boot-shaped heart (coeur en sabot) — from RV hypertrophy elevating the cardiac apex
  • Proximal aorta dilated; pulmonary trunk hypoplastic
  • RV wall markedly hypertrophied (may exceed LV thickness)
  • Left-sided chambers are normal in size

Clinical Features

FeatureDetails
CyanosisWorsens with crying, feeding, exertion; may be absent at birth
Systolic ejection murmurLeft sternal border (from RVOT obstruction, NOT the VSD)
ClubbingFingers and toes; from chronic hypoxemia
PolycythemiaCompensatory response to chronic hypoxia
SquattingOlder children squat to increase SVR and reduce R→L shunt
Chest X-rayBoot-shaped heart, decreased pulmonary vascular markings, possible right-sided aortic arch (~25%)
ECGRV hypertrophy, right axis deviation

Tet Spells (Hypercyanotic/Hypoxic Spells)

Peak incidence: 2–4 months of age
Trigger: Anything that suddenly ↓SVR (crying, defecation, fever) or causes tachycardia/hypovolemia
Vicious cycle:
↓SVR → ↑R→L shunt → ↓PaO₂, ↑PCO₂, ↓pH → hyperpnea → ↑venous return to RV → more shunting → worsening hypoxia
Clinical signs: Hyperpnea, prolonged crying, deepening cyanosis, decreased murmur intensity, possible limpness, seizures, stroke, or death.

Management of Tet Spells (Rosen's Box 165.8)

  1. Knee-to-chest position (or squatting) — increases SVR, reduces R→L shunt
  2. Supplemental oxygen (limited effect alone)
  3. Morphine 0.1–0.2 mg/kg IV/IM (sedation, ↓catecholamines) — note risk of histamine-mediated vasodilation
  4. Fentanyl 1 µg/kg IV/IM or 1.5–2 µg/kg intranasal (preferred over morphine)
  5. Midazolam 0.2–0.3 mg/kg intranasal
  6. Ketamine 1–2 mg/kg IV or 3–5 mg/kg IM — excellent (↑SVR + sedation)
  7. NaHCO₃ 1 mEq/kg IV — if metabolic acidosis (pH <7.4)
  8. Phenylephrine 0.01–0.02 mg/kg IV — α-agonist to ↑SVR
  9. Propranolol 0.1–0.2 mg/kg IV — may reduce infundibular spasm
  10. IV fluids — to ↑preload and pulmonary flow

Associated Defects

  • Right-sided aortic arch (~25%)
  • ASD
  • Anomalous coronary artery origin (left coronary from right coronary artery in ~5% — critical surgical relevance)
  • Pulmonary atresia with VSD = extreme form of ToF

Surgical Management

Palliative (staged)

  • Modified Blalock-Taussig (BT) shunt: subclavian artery → ipsilateral pulmonary artery anastomosis
  • Used when: severe cyanosis, very narrow RVOT, hypoplastic central pulmonary arteries

Definitive Repair

  • VSD closure + RVOT relief (infundibular resection ± transannular patch across pulmonary valve annulus)
  • Preferred: early single-stage repair in infancy
  • Surgical mortality: ~5–10% in uncomplicated cases within first 2 years
  • PGE₁ (prostaglandin E₁) infusion may be needed pre-operatively to maintain PDA patency in severely cyanotic neonates

Post-repair Residua (almost universal)

  • Pulmonary regurgitation (PR) — most common long-term problem
  • RV dilatation, RVOT aneurysm
  • Residual RVOT obstruction or VSD
  • Aortic root dilatation
  • Right bundle branch block (from right ventriculotomy)
  • Complete heart block, ventricular arrhythmias
  • CMR is gold standard for RV assessment post-repair; guides timing of pulmonary valve replacement

Pulmonary Valve Replacement

  • Surgical redo vs. transcatheter pulmonary valve replacement (TPVR) — both are options; recent 2025 systematic review (PMID 40122137) compared outcomes
  • Timing of intervention guided by RV volumes/function on CMR

Recent Evidence

  • Primary vs. staged repair in symptomatic neonates (Meta-analysis, Cardiol Young 2024; PMID 39444206): systematic review comparing outcomes of primary vs. staged surgical approach in symptomatic neonates.
  • Surgical vs. transcatheter pulmonary valve redo (Expert Rev Cardiovasc Ther 2025; PMID 40122137): systematic review of redo pulmonary valve options in repaired ToF patients.

Sources: Robbins & Kumar Basic Pathology | Rosen's Emergency Medicine | Grainger & Allison's Diagnostic Radiology | The Developing Human (Moore) | Braunwald's Heart Disease

How crying fever decreases SVR

Finding Sources
Finding Sources
Searching the Web

how does crying decrease systemic vascular resistance SVR physiology

Finding Sources
Finding Sources
Finding Sources
Searching the Web

fever decreases SVR mechanism prostaglandin nitric oxide vasodilation physiology

This is an important clarification — crying and fever are two separate triggers, each decreasing SVR through different mechanisms. The textbooks (and Merck Manual) actually categorize them differently.

How Crying and Fever Each Affect SVR

First — A Clarification on the Textbook Statement

Looking back at Rosen's and the Merck Manual carefully, the triggers for tet spells are listed as:
  • ↓ SVR triggers: Playing, kicking legs on awakening, vigorous physical activity
  • ↓ O₂ saturation triggers: Crying, defecating
  • Other: Tachycardia, hypovolemia
Crying is not primarily a direct SVR-lowering stimulus — its main effect is different. Here's the full breakdown:

1. Crying → ↑ Intrathoracic Pressure → ↑ Venous Return → Worsens Shunting

Crying involves a Valsalva-like maneuver and forceful expiratory effort:
  • The child strains and holds breath during a cry, raising intrathoracic pressure transiently
  • This compresses pulmonary vasculature, increasing pulmonary vascular resistance (PVR) and reducing pulmonary blood flow
  • Simultaneously, crying causes agitation and catecholamine release (sympathetic activation), which:
    • ↑ Heart rate → shortens RV filling time
    • Causes infundibular (RVOT) spasm via β-adrenergic stimulation of infundibular muscle → worsens RVOT obstruction
    • The increased venous return overwhelms the obstructed RV, forcing more blood across the VSD into the aorta
So crying's primary mechanism is ↑ RVOT obstruction + ↑ PVR, not ↓SVR. The result is the same — more R→L shunting — but via a different pathway.
This is why morphine helps tet spells: it suppresses the catecholamine surge and reduces the cry-driven agitation, breaking the infundibular spasm cycle.

2. Fever → ↓ SVR via Peripheral Vasodilation

Fever decreases SVR through direct vascular mechanisms:
MediatorMechanism
PGE₂ (prostaglandin E₂)Released during fever via COX → arachidonic acid → PGH₂ → PGE₂; acts on vascular smooth muscle to cause vasodilation (same prostaglandins that cause the flushed, warm skin of fever)
Nitric Oxide (NO)Cytokine-stimulated endothelial NO release → cGMP in smooth muscle → relaxation → vasodilation
Direct thermal effectHeat itself causes smooth muscle relaxation in arterioles (metabolic vasodilation)
Increased metabolic demandFever raises tissue O₂ consumption → local metabolic byproducts (CO₂, lactate, adenosine) cause local arteriolar dilation → ↓ SVR
This is why febrile children with ToF are at risk: the systemic vasodilation from fever lowers the "wall" of SVR that normally keeps blood flowing left-to-right (or balanced), tipping the balance toward R→L shunting across the VSD.

Summary: Pathways to R→L Shunting

CRYING                          FEVER
  ↓                               ↓
Agitation + catecholamines     PGE₂, NO, heat
  ↓                               ↓
Infundibular spasm             Peripheral vasodilation
↑ RVOT obstruction             ↓ SVR
  ↓                               ↓
↑ RV pressure                  Pressure gradient shifts
  ↓                               ↓
  └──────────────────────────────┘
         ↑ Right-to-Left shunting across VSD
                   ↓
            ↑ Cyanosis (Tet Spell)
Both converge on the same endpoint but through mechanistically distinct pathways — which is why treatment targets both (knee-chest/phenylephrine for SVR; morphine/fentanyl for infundibular spasm/catecholamine surge).
This is a shared conversation. Sign in to Orris to start your own chat.